Verdict
Pros
- Both branded and compounded paths in one membership, no forced choice.
- Three-day average time to first prescription with a synchronous video visit.
- Clinic and telehealth hybrid model for patients near a location.
- Quick titration support reported by members.
- HSA and FSA eligible.
Cons
- The $175/mo price requires a 6-month medication prepay ($600 upfront) with no refund once medication ships.
- No month-to-month medication option is published; the 4-month supply ($499) is the shortest, and the prepay tiers feel like lock-in.
- Branded pricing opaque until the consult.
- Inconsistent provider matching across visits.
- Not available in Louisiana or Mississippi.
Buyers who want a choice between branded and compounded GLP-1 from one program.
Anyone allergic to multi-month prepay tiers or who wants pure flat monthly billing.
Pricing
About $175/mo: $75/mo membership (first month free) + semaglutide $600 per 6-month supply. The 4-month supply ($499) is about $200/mo with less paid upfront. 4-month minimum.
| Signup / one-time | None |
| Membership / subscription | $75/mo |
| Medication (varies by dose) | $100–$125/mo |
| All-in, lowest maintenance dose | $175/mo |
Price since we started tracking
| Week | Price |
|---|---|
| May 25 | $200/mo |
| Jun 1 | $200/mo |
| Jun 8 | $200/mo |
| Jun 15 | $200/mo |
| Jun 22 | $200/mo |
| Jun 29 | $200/mo |
| Jul 6 | $200/mo |
| Jul 13 | $200/mo |
| Jul 20 | $200/mo |
| Jul 27 | $200/mo |
| Aug 3 | $200/mo |
| Aug 10 | $175/mo |
| Aug 17 | $175/mo |
| Aug 24 | $175/mo |
| Aug 31 | $175/mo |
Headline maintenance price, read off the program's published pricing every Monday. Tracking since May 2026, 15 checks so far. See the full price tracker.
See how Ivim Health compares with every path in our GLP-1 cost guide, or check the live price index for the full chart.
Lock-in & cancellation
6-mo prepay
Membership is month-to-month. Medication is sold as 4- or 6-month prepaid supplies with no refund on unused months once medication has shipped. Our headline $175/mo requires the 6-month prepay; the 4-month supply is about $200/mo.
How to cancel: Membership is month-to-month. Medication is sold as 4- or 6-month prepaid supplies with no refund on unused months once medication has shipped.
Medication options
Branded routed through retail pharmacies on insurance or cash. Compounded sourced through partner 503A pharmacies under personalization claims.
A licensed US pharmacy makes compounded semaglutide and tirzepatide to a prescription. They are not FDA-approved and they are not Wegovy, Ozempic, Zepbound or Mounjaro. The FDA does not review them for safety, effectiveness or quality, and their formulation, including the salt form, can differ from the approved drug. Confirm the active ingredient and the pharmacy with the prescriber. The FDA removed semaglutide from the drug-shortage list in February 2025, which narrowed the legal basis for routine 503A compounding of exact-copy semaglutide. Ivim Health uses a personalized-formulation model: the compound adds an active ingredient such as vitamin B12. Some state pharmacy boards tightened oversight through 2025 and 2026. For the full background see our compounded vs FDA-approved breakdown.
FDA-approved branded
- Wegovy
- Zepbound
- Mounjaro
- Ozempic
Compounded
- Compounded semaglutide
- Compounded tirzepatide
Other medications
- Metformin
- Phentermine
Read the buyer's guide for the medications Ivim Health covers: compounded semaglutide, compounded tirzepatide.
The drug comparison table covers semaglutide vs tirzepatide on cost, side effects, and clinical evidence side by side.
Where it's compounded
| Pharmacy | Not publicly disclosed |
| Regulatory model | Not specified |
| Accreditation | Claims 'USP/PCAB-compliant' but does not name the pharmacy |
| Disclosure | Not publicly disclosed |
| Source | Primary source → |
Ivim Health does not publicly name the pharmacy that compounds its GLP-1 medications. This is a transparency gap, not a statement about medication safety. Questions worth asking any program: is the pharmacy a named 503A or 503B facility, is it US-licensed, does it carry independent accreditation (PCAB, NABP), and does it provide sterility and potency testing results on request?
FDA warning letter WL-721816 (February 20, 2026) for misbranding. Ivim does not name its compounding pharmacy.
For background on 503A vs 503B regulation and how to vet a compounding pharmacy, see Which pharmacy compounds your GLP-1, and why it matters.
Onboarding experience
Time to first prescription: 3 days.
Consultation type: Live video visit with nurse practitioner or physician.
Requirements: Medical history, baseline labs (Ivim can order), short video visit, weight check..
Ivim Health reviews: what members report
Treated as a credible mid-tier choice. Buyers who do the math on the 6-month bundle stay; those expecting Henry-style simplicity get frustrated by prepay terms.
What works
- Branded option available
- Bundle pricing competitive
- Clinic and telehealth hybrid
- Quick titration support
What to watch
- Prepay tiers feel like lock-in
- Refund policy strict on shipped med
- Branded pricing opaque until consult
- Inconsistent provider matching
How we scored Ivim Health
Five dimensions, ten points each, weighted equally. Overall is the simple average.
Transparency
Terms
Experience
Options
Reviews
The member-reviews pillar reflects Ivim Health’s Trustpilot rating of 4.9/5. See it on Trustpilot →
Frequently asked questions
Is Ivim Health legit?
Is Ivim Health a scam?
Can I get branded Wegovy or Zepbound through Ivim?
What happens if I cancel mid-bundle?
Do they have physical clinics?
Partner programs
If Ivim Health isn't the right fit, here are three programs to consider next:
These programs pay GLP Chart a commission when you join. Disclosure
Before committing to a cash-pay path, check whether your insurance covers a GLP-1 at the payer coverage center. On Medicaid, see Medicaid GLP-1 coverage by state first. If you need PA paperwork, the prior authorization letter library has templates for all major plans. Already denied? The appeal letter library has 120 templates by denial reason.
Learn the category before you commit
Read these before signing up for any GLP-1 telehealth program, Ivim Health included:
The FDA sent Ivim Health a warning letter on February 20, 2026, citing misbranded compounded semaglutide and tirzepatide. The FDA has not published a close-out letter. Source: FDA
